Matthew Tate

2PUBLICATIONS
5CO-AUTHORS
Implementation science and evaluationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 08, 2026
Impact of a national mesothelioma network on outcomes including survival.

|Jun 24, 2025
Clinical effectiveness, safety, and viral mutagenicity of oral favipiravir for COVID-19: results from a community-based, open-label, randomized Phase III trial.

Matthew Tate, Christopher J R Illingworth, Gordon MacGregor

Pageof 1

Frequent Collaborators

2 joint publications

Kevin G Blyth

1 joint publications

Emma Thomson

1 joint publications

Selina Tsim

1 joint publications

Gordon W Cowell